Brought to you by 
Eurolab to sell Cardiome's Brinavess in Argentina
27 Aug 2014
Executive Summary
US cardiovascular drug developer Cardiome Pharma Corp. licensed Eurolab Especialidades Medicinales de Eurofar SRL exclusive rights to sell and distribute Brinavess (vernakalant intravenous) in its home country of Argentina.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Eurolab to sell Cardiome's Brinavess in Argentina
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice